Preparation, preparation, preparation: The influence of adrenergic agonism in cardiac ventricular repolarisation assays used in preclinical drug development and drug safety pharmacology.
Hancox
Jules C
JC
Curtis
Michael J
MJ
D000200:Action Potentials / Q000187:drug effects*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D004353:Drug Evaluation, Preclinical; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006352:Heart Ventricles / Q000187:drug effects; D008133:Long QT Syndrome / Q000503:physiopathology; D026902:Potassium Channel Blockers / Q000494:pharmacology; D011817:Rabbits; D016276:Ventricular Function
D000318:Adrenergic beta-Agonists; D026902:Potassium Channel Blockers